Biosafety Evaluation of Nanoparticles in View of Genotoxicity and Carcinogenicity Studies: A Systematic Review

Abstract:

Nanoparticles (NPs) are used in various forms in consumer products including, cosmetics, food packaging, textiles and also in air and water cleaning, production of electro chromic windows, or smart windows and gas sensors. Many NPs have also been evaluated for potential use in biomedical applications as efficient delivery carriers for cancer diagnosis and therapy. Nowadays, NPs are being developed to create fascinating nanotechnology products. To develop NPs for broad applications, potential risks to human health and the environment should be evaluated and taken into consideration. Again, to translate these nanomaterials to the clinic and industrial domains, their biosafety needs to be verified, particularly in terms of genotoxic and carcinogenic effects. To evaluate evidenced-based practices for NPs safety, we performed a systematic review of the published English-language literature. We performed a systematic keyword search of PubMed for original research articles pertaining to reports on assessment of risks due to carcinogenic and mutagenic effects by different NPs. We identified 362 original articles available for analysis. The included studies were published between 1993 and 2012. The in vivo or in vitro genotoxicity studies were performed on only 18 out of 148 kinds of NPs in industry today. Likewise, the carcinogenicity investigations were performed on only 14 out of 148 NPs. The 10 types of the NPs including some titanium, aluminium, carbon black and silver molecules were found to have both mutagenic and carcinogenic potential. The important finding was also that there is a lack of systematic assessment of the DNA damaging and carcinogenic potential of NPs in spite of their extensive use in nanotechnological applications.

• Periodical: Key Engineering Materials (Volume 543)
• Pages: 200-203
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.543.200
• Online since: March 2013
• Authors: Hasan Turkez, Kubra Celik, Bulent Cakmak
• Keywords: Biosafety, Genotoxicity, In Vivo, Nanoparticle, Risk Assessment, Tungsten Trioxide

References

[1] M. Horie and Y. Morimoto: JUOEH. Vol. 34 (2012), p.57.

[2] C.S. Yah, G.S. Simate and S.E. Iyuke SE: Pak. J. Pharm. Sci. Vol. 25 (2012), p.477.

[3] H. Tsuda, J. Xu, Y. Sakai, M. Futakuchi, K. Fukamachi: Asian Pac. J. Cancer Prev. Vol 10 (2009), p.975.

[4] H. Norppa, J. Catalán, G. Falck, K. Hannukainen, K. Siivola and K. Savolainen: J. Biomed. Nanotechnol. Vol. 7 (2011), p.19.

DOI: 10.1166/jbn.2011.1179

[5] G. Hasegawa, M. Shimonaka, Y. Ishihara: J. Appl. Toxicol. Vol. 32 (2012), p.72.

[6] A. Beyerle, A.S. Long, P.A. White, T. Kissel, T. Stoeger: Mol. Pharm. Vol. 8 (2011), p.976.

[7] F. Geyikoglu F and H. Turkez: Environ. Toxicol. Pharmacol. Vol. 26 (2008), p.342.

[8] A.L. Di Virgilio, M. Reigosa, P.M. Arnal and M. Fernández Lorenzo de Mele: M. J. Hazard. Mater. Vol. 177 (2010), p.711.

[9] J.A. Bourdon, A.T. Saber, N.R. Jacobsen, K.A. Jensen, A.M. Madsen, J.S. Lamson, H. Wallin, P. Møller, S. Loft, C.L. Yauk and U.B. Vogel: Part. Fibre. Toxicol. Vol. 9 (2012), p.5.

DOI: 10.1186/1743-8977-9-5

[10] R. Colognato, A. Bonelli, J. Ponti, M. Farina, E. Bergamaschi, E. Sabbioni, L. Mutagenesis. Vol. 23 (2008), p.377.

DOI: 10.1093/mutage/gen024

[11] X. Pan, J.E. Redding, P.A. Wiley, L. Wen , J.S. McConnell and B. Zhang: Chemosphere. Vol. 79 (2010), p.113.

[12] J.J. Li, S.L. Lo, C.T. Ng, R.L. Gurung, D. Hartono, M.P. Hande, C.N. Ong, B.H. Bay, L.Y. Yung: Biomaterials. Vo. 32 (2011), p.5515.

DOI: 10.1016/j.biomaterials.2011.04.023

[13] M. Könczöl, S. Ebeling, E. Goldenberg, F. Treude, R. Gminski, R. Gieré, B. Grobéty, B. Rothen-Rutishauser, I. Merfort and V. Mersch-Sundermann: V. Chem. Res. Toxicol. Vol. 25 (2011), p.146.

DOI: 10.1021/tx200051s

[14] E. Demir, G. Vales, B. Kaya, A. Creus and R. Marcos: Nanotoxicol. Vol. 5 (2011), p.417.

[15] J.P.S. Wise, B.C. Goodale, S.S. Wise, G.A. Craig, A.F. Pongan, R.B. Walter, W.D. Thompson, A.K. Ng, A.M. Aboueissa, H. Mitani, M.J. Spalding and M.D. Mason: Aquat. Toxicol. Vol. 97 (2010), p.34.

DOI: 10.1016/j.aquatox.2009.11.016

[16] Y. Li , D.H. Chen, J. Yan, Y. Chen, R.A. Mittelstaedt, Y. Zhang, A.S. Biris, R.H. Heflich and T. Chen: Mutat. Res. (2012), in press.

[17] S. Barillet, M.L. Jugan, M. Laye, Y. Leconte, N. Herlin-Boime, C. Reynaud and M. Carrière: Toxicol. Lett. Vol. 198 (2010), p.324.

DOI: 10.1016/j.toxlet.2010.07.009

[18] M.L. Jugan, S. Barillet, A. Simon-Deckers, N. Herlin-Boime, S. Sauvaigo, T. Douki and M. Carriere: Nanotoxicol. (2012), in press.

DOI: 10.3109/17435390.2011.587903

[19] K.M. Ramkumar, C. Manjula, G. Kumar, M.A. Kanjwal, T.V. Sekar, R. Paulmurugan and P. Rajaguru: Eur. J. Pharm. Biopharm. (2012), in press.

[20] H. Jiang, F. Liu, H. Yang and Y. Li: Biol. Trace. Elem. Res. Vol. 146 (2012), p.23.

[21] JJ. Wang, B.J. Sanderson and H. Wang: Mutat. Res. Vol. 628 (2007), p.99.

[22] H. Turkez: Exp. Toxicol. Pathol. Vol. 63 (2011), p.453.

[23] H. Turkez and F. Geyikoglu: Toxicol. Ind. Health. Vol. 23 (2007), p.19.

[24] F. Geyikoglu and H. Turkez: Environ. Toxicol. Pharmacol. Vol. 26 (2008), p.34.

[25] A. Kumar, A.K. Pandey, S.S. Singh, R. Shanker and A. Dhawan: Chemosphere. Vol. 83 (2011), p.1124.

[26] V. Sharma, S.K. Singh, D. Anderson, D.J. Tobin and A. Dhawan: A. J. Nanosci. Nanotechnol. Vol. 11 (2011), p.3782.

[27] H. Becker, F. Herzberg, A. Schulte and M. Kolossa-Gehring: Int. J. Hyg. Environ. Health. Vol. 214 (2011), p.231.

[16] M. Roller: Inhal. Toxicol. Vol. 21 (2009), p.144.

[28] M. Roller: Inhal. Toxicol. Vol. 21 (2009), p.144.

[29] Y.J. Chae, C.H. Pham, J. Lee, E. Bae, J. Yi and M.B. Gu: Aquat. Toxicol. Vol. 94 (2009), p.320.

[30] S. Dey, V. Bakthavatchalu, M.T. Tseng, P. Wu, R.L. Florence, E.A. Grulke, R.A. Yokel, S.K. Dhar, H.S. Yang, Y. Chen and D.K. St Clair: Carcinogenesis. Vol. 29 (2008), p. (1920).

DOI: 10.1093/carcin/bgn175

[31] M. Yokohira, N. Hashimoto, K. Yamakawa, S. Suzuki, K. Saoo, T. Kuno, K. Imaida: J. Toxicol. Pathol. Vol. 22 (2009), p.71.

DOI: 10.1293/tox.22.71

[32] M.A. Nelson, F.E. Domann, G.T. Bowden, S.B. Hooser, Q. Fernando and D.E. Carter: Toxicol. Ind. Health. Vol. 9 (1993), p.623.